(Q37988979)

26 August 2017

title

Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism (English)

1 reference

26 August 2017

Michael R Rutledge

1

1 reference

26 August 2017

Victor Farah

2

1 reference

26 August 2017

Adedayo A Adeboye

3

1 reference

26 August 2017

Michael R Seawell

4

1 reference

26 August 2017

Syamal K Bhattacharya

5

1 reference

26 August 2017

Karl T Weber

6

1 reference

26 August 2017

publication date

1 April 2013

1 reference

Cardiovascular Drugs and Therapy

26 August 2017

published in

1 reference

26 August 2017

volume

27

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

161-170

1 reference

Aldosterone--villain or bystander?

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Aldosterone: a cardiovascular risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Aldosterone: a risk factor for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

From inflammation to fibrosis: a stiff stretch of highway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Aldosterone blockade: an emerging strategy for abrogating progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Response of adrenal cells to parathyroid hormone stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Human adipocytes secrete mineralocorticoid-releasing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Hyperparathyroidism and the calcium paradox of aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Oxidative stress and antioxidant treatment in hypertension and the associated renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Circulating biomarkers of collagen metabolism in cardiac diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Towards a new paradigm about hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Mineralocorticoids, hypertension, and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Renal handling of calcium and phosphate during mineralocorticoid "escape" in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Role of nitric oxide in the control of renal function and salt sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Primary hyperparathyroidism in a patient with Conn's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Loss of bone minerals and strength in rats with aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Spironolactone improves angiotensin-induced vascular changes and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Aldosteronism and a proinflammatory vascular phenotype: role of Mg2+, Ca2+, and H2O2 in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Effects of verapamil on the abnormalities in fatty acid oxidation of myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

The action of vitamin D and parathyroid hormone in vitro on calcium uptake and release by kidney mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

NCLX is an essential component of mitochondrial Na+/Ca2+ exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Altered Ca2+ homeostasis and impaired mitochondrial function in cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Aldosterone regulation of T-type calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Parathyroid hormone-related peptide improves contractile responsiveness of adult rat cardiomyocytes with depressed cell function irrespectively of oxidative inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Calcium paradox of aldosteronism and the role of the parathyroid glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Evidence for alteration of the vitamin D-endocrine system in blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Poor outcome in end-stage heart failure patients with low circulating calcitriol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Vitamin D and vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Parathyroid hormone-related protein is produced in the myocardium and increased in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Pathogenesis of bone loss in heart transplant candidates and recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Congestive heart failure is associated with the rate of bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Fracture risk in men with congestive heart failure risk reduction with spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Diuretics and bone loss in rats with aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Serum intact parathyroid hormone levels predict hospitalisation for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Plasma parathyroid hormone and risk of congestive heart failure in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Vitamin D, parathyroid hormone, and cardiovascular events among older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Parathyroid hormone as a mortality predictor in frail aged inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Cardiac troponin and outcome in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6378-0

10.1007/S10557-012-6378-0

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference